Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual β-Cell FunctionKIELGAST, Urd; HOLST, Jens J; MADSBAD, Sten et al.Diabetes (New York, NY). 2011, Vol 60, Num 5, pp 1599-1607, issn 0012-1797, 9 p.Article

The insulin-resistant phenotype of polycystic ovary syndromeSVENDSEN, Pernille Fog; MADSBAD, Sten; NILAS, Lisbeth et al.Fertility and sterility. 2010, Vol 94, Num 3, pp 1052-1058, issn 0015-0282, 7 p.Article

The influence of GLP-1 on glucose-stimulated insulin secretion: Effects on β-cell sensitivity in type 2 and nondiabetic subjectsKJEMS, Lise L; HOLST, Jens J; VØLUND, Aage et al.Diabetes (New York, NY). 2003, Vol 52, Num 2, pp 380-386, issn 0012-1797, 7 p.Article

Additive effects of glucagon-like peptide 1 and pioglitazone in patients with type 2 diabetesZANDER, Mette; CHRISTIANSEN, Allan; MADSBAD, Sten et al.Diabetes care. 2004, Vol 27, Num 8, pp 1910-1914, issn 0149-5992, 5 p.Article

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group studyZANDER, Mette; MADSBAD, Sten; MADSEN, Jan Lysgaard et al.Lancet (British edition). 2002, Vol 359, Num 9309, pp 824-830, issn 0140-6736Article

Incretin hormone secretion in women with polycystic ovary syndrome : roles of obesity, insulin sensitivity, and treatment with metforminSVENDSEN, Pernille Fog; NILAS, Lisbeth; MADSBAD, Sten et al.Metabolism, clinical and experimental. 2009, Vol 58, Num 5, pp 586-593, issn 0026-0495, 8 p.Article

Comparison of the soluble basal Insulin analog Insulin detemir with NPH insulin : A randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapyHERMANSEN, Kjeld; MADSBAD, Sten; PERRILD, Hans et al.Diabetes care. 2001, Vol 24, Num 2, pp 296-301, issn 0149-5992Article

Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell FunctionKIELGAST, Urd; KRARUP, Thure; HOLST, Jens Juul et al.Diabetes care. 2011, Vol 34, Num 7, pp 1463-1468, issn 0149-5992, 6 p.Article

Effect of Glucagon-Like Peptide-1 on α- and β-Cell Function in C-Peptide-Negative Type 1 Diabetic PatientsKIELGAST, Urd; ASMAR, Meena; MADSBAD, Sten et al.The Journal of clinical endocrinology and metabolism. 2010, Vol 95, Num 5, pp 2492-2496, issn 0021-972X, 5 p.Article

Intramyocellular triglyceride content in man, influence of sex, obesity and glycaemic controlHAUGAARD, Steen B; HUILING MU; VAAG, Allan et al.European journal of endocrinology. 2009, Vol 161, Num 1, pp 57-64, issn 0804-4643, 8 p.Article

Dietary intervention increases n-3 long-chain polyunsaturated fatty acids in skeletal muscle membrane phospholipids of obese subjects. ūmplications for insulin sensitivityHAUGAARD, Steen B; MADSBAD, Sten; HØY, Carl-Erik et al.Clinical endocrinology (Oxford. Print). 2006, Vol 64, Num 2, pp 169-178, issn 0300-0664, 10 p.Article

Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjectsVILSBØLL, Tina; KRARUP, Thure; MADSBAD, Sten et al.Regulatory peptides. 2003, Vol 114, Num 2-3, pp 115-121, issn 0167-0115, 7 p.Article

Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetesZANDER, Mette; TASKIRAN, Mustafa; TOFT-NIELSEN, Mai-Britt et al.Diabetes care. 2001, Vol 24, Num 4, pp 720-725, issn 0149-5992Article

Glucose-Dependent Insulinotropic Polypeptide May Enhance Fatty Acid Re-esterification in Subcutaneous Abdominal Adipose Tissue in Lean HumansASMAR, Meena; SIMONSEN, Lene; MADSBAD, Sten et al.Diabetes (New York, NY). 2010, Vol 59, Num 9, pp 2160-2163, issn 0012-1797, 4 p.Article

Incretin-Based Therapies: Viewpoints on the way to consensusNAUCK, MichaEL A; GARBER, Alan; VILSBØLL, Tina et al.Diabetes care. 2009, Vol 32, Num 3, pp 5223-5231, issn 0149-5992, 9 p., SUPConference Paper

Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients who display fat redistributionHAUGAARD, Steen B; ANDERSEN, Ove; HALSALL, Ian et al.Metabolism, clinical and experimental. 2007, Vol 56, Num 7, pp 939-946, issn 0026-0495, 8 p.Article

Improved glycemic control with no weight increase n patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog Liraglutide (NN221): A 12-week, double-blind, randomized, controlled trialMADSBAD, Sten; SCHMITZ, Ole; RANSTAM, Jonas et al.Diabetes care. 2004, Vol 27, Num 6, pp 1335-1342, issn 0149-5992, 8 p.Article

Do the Actions of Glucagon-Like Peptide-1 on Gastric Emptying, Appetite, and Food Intake Involve Release of Amylin in Humans?ASMAR, Meena; BACHE, Michael; KNOP, Filip K et al.The Journal of clinical endocrinology and metabolism. 2010, Vol 95, Num 5, pp 2367-2375, issn 0021-972X, 9 p.Article

Glucose production, oxidation and disposal correlate with plasma lactate levels in HIV-infected patients on HAARTHAUGAARD, Steen B; ANDERSEN, Ove; MADSBAD, Sten et al.The Journal of infection. 2007, Vol 54, Num 1, pp 89-97, issn 0163-4453, 9 p.Article

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: A population-based studyJEPPESEN, Jørgen; HANSEN, Tine W; RASMUSSEN, Susanne et al.Journal of the American College of Cardiology. 2007, Vol 49, Num 21, pp 2112-2119, issn 0735-1097, 8 p.Article

Growth factors, glucose and insulin kinetics after low dose growth hormone therapy in HIV-lipodystrophyHAUGAARD, Steen B; ANDERSEN, Ove; FLYVBJERG, Allan et al.The Journal of infection. 2006, Vol 52, Num 6, pp 389-398, issn 0163-4453, 10 p.Article

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patientsVILSBØLL, Tina; KRARUP, Thure; DEACON, Carolyn F et al.Diabetes (New York, NY). 2001, Vol 50, Num 3, pp 609-613, issn 0012-1797Article

Altered skeletal muscle fiber composition and size precede whole-body insulin resistance in young men with low birth weightJENSEN, Christine B; STORGAARD, Heidi; MADSBAD, Sten et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 4, pp 1530-1534, issn 0021-972X, 5 p.Article

Young, low-birth-weight men are not more susceptible to the diabetogenic effects of a prolonged free fatty acid exposure than matched controlsJENSEN, Christine B; STORGAARD, Heidi; HOLST, Jens Juul et al.Metabolism, clinical and experimental. 2005, Vol 54, Num 10, pp 1398-1406, issn 0026-0495, 9 p.Article

Insulin secretion after short- and long-term low-grade free fatty acid infusion in men with increased risk of developing type 2 diabetesSTORGAARD, Heidi; JENSEN, Christine B; VAAG, Allan A et al.Metabolism, clinical and experimental. 2003, Vol 52, Num 7, pp 885-894, issn 0026-0495, 10 p.Article